IZ Express

Issue 1801: February 26, 2025

Top Stories
 
Immunize.org Website and Clinical Resources 
 
Featured Resources
 
Notable Publications
 
Global News
 
Upcoming Events

Top Stories

Immunize.org reviews, updates “Ask the Experts: Documenting Vaccination,” and adds three new questions

Immunize.org reviewed the content of its Ask the Experts: Documenting Vaccination web page, updating answers, including hyperlinks to CDC references that changed during CDC’s recent website restructuring program. Three new questions and answers were added:

  • What is the Countermeasures Injury Compensation Program (CICP)? 
  • Does providing a digital copy of a VIS count, or must we give a paper VIS? 
  • What is a vaccine EUA fact sheet and when do I use one? 



Immunize.org's Ask the Experts main page leads you to 30 distinct web pages on dozens of topics with more than 1,300 common or challenging questions and answers (Q&As) about vaccines and their administration. Immunize.org's team of experts includes Kelly L. Moore, MD, MPH (team lead); Carolyn B. Bridges, MD, FACP; Iyabode Beysolow, MD, MPH; and Jane R. Zucker, MD, MSc.

Related Links


Immunize.org reviews, updates “Ask the Experts: Billing & Reimbursement,” and adds a question on Medicaid policies

Immunize.org reviewed and updated the content of its Ask the Experts: Billing & Reimbursement web page, updating answers, including CDC website links. The answers reflect current Medicare and Medicaid payment policies.

New questions and answers were added: What vaccines are covered by Medicaid? Does coverage vary by state? 

Related Links


Immunize.org updates two "Questions and Answers" resources, one for Haemophilus influenzae type b (Hib) and one for pneumococcus

Immunize.org updated two of its "Questions and Answers" resources. 

    

Related Links


“Genomic and Wastewater Surveillance Data to Guide a Hepatitis A Outbreak Response—Los Angeles County, March 2024–June 2024” published in MMWR 

CDC published Genomic and Wastewater Surveillance Data to Guide a Hepatitis A Outbreak Response—Los Angeles County, March 2024–June 2024 on February 20 in MMWR. A portion of the summary appears below. 

Routine hepatitis A virus (HAV) infection surveillance cannot detect patients who don’t seek clinical care, receive testing, or whose cases are not reported. . . .

During March 12–April 18, 2024, three HAV cases were identified among persons experiencing homelessness who had a matching HAV subgenotype, indicating a potential common transmission chain. A concurrent approximately seven-times increase in HAV wastewater concentrations above baseline, when a similar number of cases were reported, demonstrated the potential for wastewater testing to detect unreported HAV transmission. . . .

Genomic analysis and wastewater testing can complement traditional case-based surveillance to identify and better characterize HAV outbreaks.

Access the MMWR article in HTML or PDF.

Related Link

  • CDC: MMWR main page providing access to the MMWR family of publications

March 4 is International HPV Awareness Day; spread the word that HPV vaccination is cancer prevention 

Tuesday, March 4, is International HPV Awareness Day, a great time to spread the word about how HPV vaccine can reduce the risk of cancers caused by certain types of this common virus. HPV vaccination should be completed routinely before age 13 years, and as soon as feasible for all unvaccinated adolescents and young adults through age 26. Adults age 27 through 45 who want protection may be vaccinated after a discussion with their healthcare provider.

Vaccination before sexual contact is the most effective way to protect against HPV-related cancers including cervical, vaginal, vulvar, anal, penile, and head and neck cancers. Vaccination prevents almost 90% of cervical cancer cases. HPV is also the most common cause of oral cancers in men. Because everyone is at risk for HPV-related cancers, it's important to receive the HPV vaccine series according to recommended vaccination schedules.



You can raise awareness with International Papillomavirus Society (IPVS) campaign resources in 13 languages and by including #OneLessWorry in your social media posts.

Related Links


Worst influenza season in 15 years continues to be severe across the country; vaccination can still protect

For week 7, ending February 15, CDC’s Weekly U.S. Influenza Surveillance Report, FluView, showed influenza-like illness activity at high to very high levels in 44 of 49 reporting jurisdictions. CDC classified this season as a high-severity season for people of all ages. During week 7, 6.8% of outpatient visits were for influenza-like illness, well above the epidemic threshold of 3.0% for the twelfth consecutive week. Eighteen pediatric deaths associated with seasonal influenza virus infection were reported during week 7, bringing the 2024–25 season total to 86 pediatric deaths.



RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) for weekly reports of hospitalizations due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV. COVID-19 vaccination is recommended for everyone age 6 months and older; RSV vaccination at this point in the season is recommended for certain high-risk adults age 60 through 74 and all adults age 75 years and older. RSV immunization of infants and certain high-risk toddlers with nirsevimab (Beyfortus, Sanofi) is recommended until the end of March.

Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard shows the latest statistics. Coverage level estimates from IIS data submitted to CDC through February 8 appear below.

  • For children 6 months–17 years:
    • Among 32 reporting state and city IIS jurisdictions, influenza vaccination coverage ranged from 13.3% to 42.0%.
    • Among 7 reporting U.S. territorial and affiliated island jurisdictions, coverage ranged from 0.0% to 32.3%.
  • For adults 18 years and older:
    • Among 32 reporting state and city IIS jurisdictions, influenza vaccination coverage ranged from 9.9% to 39.4%.
    • Among 7 reporting U.S. territorial and affiliated island jurisdictions, coverage ranged from 1.2% to 15.5%.

CDC recommends everyone age 6 months and older get annual influenza vaccination. Given the high levels of circulating influenza across the country, vaccination remains important for all eligible, unvaccinated people.

Identify pharmacies in your area that may offer influenza and COVID-19 vaccines by entering a zip code in the VaccineFinder on Vaccines.gov or Vacunas.gov.

Related Links


Immunize.org’s Influenza Vaccination Honor Roll for healthcare worker vaccination requirements welcomes a new facility 

Immunize.org's Influenza Vaccination Honor Roll recognizes facilities that take a stand for patient safety by implementing policies requiring healthcare personnel influenza vaccination. Immunize.org recently welcomed Saint James Health, Inc., Newark, NJ, to our honor roll.



Eligibility
  • Eligible organizations: hospitals, long-term care facilities, medical practices, pharmacies, professional organizations, health departments, and other government entities
  • Requirements:
    • Your policy must require influenza vaccination for all staff
    • The application must describe measures to prevent transmission of influenza from unvaccinated personnel to patients (e.g., masking for the entire shift)
Related Links

“Is RSV Vaccine Indicated for a 69-Year-Old with Hypertension?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube. 

This week, our featured episode from the Ask the Experts Video Series is, Is RSV Vaccine Indicated for a 69-Year-Old with Hypertension? The video describes how RSV vaccination is not recommended for a person younger than age 75 with hypertension and no other risk factors.

The 1-minute video is available on our YouTube channel, along with our full collection of quick video answers to popular Ask the Experts questions.

Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.


Journalists interview Immunize.org experts 

Journalists seek out Immunize.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a recent citation.


Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.


Immunize.org Website and Clinical Resources

Spotlight on the website: "Image Library"

Immunize.org's “Image Library” provides images of infectious diseases to educate yourself or others about vaccine-preventable diseases. Most images included are in the public domain and can be reproduced without permission. If an image is copyrighted, information is provided so you can obtain permission from the copyright holder.

To view images, click the “Clinical Resources” tab atop each Immunize.org web page. Then click Image Library on the left. Choose one of the 22 galleries shown on the right menu to view available images.



Vaccines A–Z: Mpox main page offers images from the “Image Library.” This example shows how to access the recently posted mpox photos. The right menu (under “On this page”) features a quick link to “Photos & Videos.”


Recap: Immunize.org updated one term on "Quick Chart of Vaccine-Preventable Disease Terms in Multiple Languages"

Immunize.org updated its Quick Chart of Vaccine-Preventable Disease Terms in Multiple Languages to correct the Portuguese translation for MMR. 


Featured Resources

Hepatitis B Foundation releases Hep B Birth Dose Media Toolkit

The Hepatitis B Foundation released a Hep B Birth Dose Media Toolkit to help to help raise awareness about prevention of chronic infection. The toolkit includes talking points, fact sheets, and social media messages.

View the toolkit.

Related Link


CDC offers updated PneumoRecs VaxAdvisor app for vaccine providers to easily determine any person’s pneumococcal vaccination needs

CDC offers PneumoRecs VaxAdvisor, an app to easily determine which pneumococcal vaccines a patient needs. The app is free to use in both mobile and web versions.

CDC updated the app on December 11, 2024, to reflect ACIP’s new routine adult pneumococcal vaccination recommendations beginning at age 50 instead of age 65. On the revised app, you should see three age choices, the second being 19 through 49 years. If you see different choices, remove and reinstall the app.



Access the web version or download PneumoRecs VaxAdvisor to your mobile device:


Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults

Confident healthcare provider recommendations for influenza vaccine are powerfully persuasive. This influenza season has been a tough one, and it is far from over. To help you maximize patient protection, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense website.



This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:

Older adults are at increased risk of severe influenza, COVID-19, and RSV illness, including hospitalization and death, especially if they are not up to date on these vaccinations. A clinician recommendation is the most important reason why a patient will get vaccinated.

Check out the updated 65+ Flu Defense website to assist your ongoing efforts in protecting this vulnerable population.


While supplies last, order laminated 2025 U.S. immunization schedule booklets from Immunize.org

Laminated booklets of the 2025 U.S. child and adolescent immunization schedule and the 2025 U.S. adult immunization schedule are available now in the Immunize.org shop. 

The schedules are available online as PDFs from CDC at no cost. Immunize.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given. Features include:

  • Durability: Their tough coating can be wiped down, and they can stand up to a year's worth of use.
  • Format: Each schedule is produced in an 8.5” X 11” booklet format; with color coding for easy reading, our laminated schedules replicate the original CDC formatting, including all tables and notes. The adult schedule is 16 pages and the child and adolescent schedule is 20 pages.
  • Easy access to CDC updates: The CDC online schedule includes an addendum page that will display ACIP’s new recommendations as CDC adopts them during 2025. Each Immunize.org laminated schedule addendum page includes QR codes you can scan to view or print the online addendum page as it is revised.
  • Bonus content: Both schedules include a bonus page with Immunize.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients.

       


Pricing:
 
Child and Adolescent Booklets           Adult Booklets   
1 copy: $10.50           1 copy: $10.00
2–4 copies: $10.00 each           2–4 copies: $9.50 each
5–19 copies: $9.00 each           5–19 copies: $8.50 each
20–99 copies: $8.00 each           20–99 copies: $7.50 each
100–499 copies: $6.50 each           100–499 copies: $6.00 each
500–999 copies: $5.50 each           500–999 copies: $5.00 each
1,000–1,999 copies: $4.50 each            1,000–1,999 copies: $4.00 each
2,000+ copies: $3.75 each           2,000+ copies: $3.25 each
   
Visit the Shop Immunize.org: Laminated Schedules web page to view images and preorder today!

For additional information, call 651-647-9009 or email admininfo@immunize.org.

Related Links
Notable Publications

“Dengue Outbreak and Response—Puerto Rico, 2024” published in MMWR 

CDC published Dengue Outbreak and Response—Puerto Rico, 2024 on February 20 in MMWR. Dengue vaccination in Puerto Rico is routinely recommended for children age 9 through 16 years who have laboratory evidence of past dengue infection. Although recommended, the vaccine has not been widely used. A portion of the summary appears below.

Dengue, a mosquitoborne disease that can lead to severe illness or death, is endemic in tropical and subtropical regions worldwide. The most recent outbreak in Puerto Rico occurred in 2013. . . .

During 2024, Puerto Rico reported 6,291 dengue cases and surpassed the epidemic threshold, prompting declaration of a local public health emergency. Approximately one half of patients (52.3%) were hospitalized, 264 (4.2%) had severe dengue cases, and 11 (0.2%) persons died. Persons aged 10–19 years accounted for 28.4% of severe cases. . . .

Improved case recognition and clinical management facilitate improved outcomes. To reduce mosquito bite risk, residents of and visitors to Puerto Rico should consider using repellents, wearing protective clothing, and staying in places with door and window screens.



Access the MMWR article in HTML or PDF.

Related Links


Global News

"Evaluation of National Immunization Technical Advisory Groups (NITAGs) of Middle-Income Countries in the WHO European Region; a Synopsis" published in Frontiers in Public Health

In the February 18 issue, Frontiers in Public Health published Evaluation of National Immunization Technical Advisory Groups (NITAGs) of Middle-Income Countries in the WHO European Region; a Synopsis. Immunize.org's project consultant, Lisa Jacques-Carroll, MA, is an author of the article. Portions of the abstract appear below.

A National Immunization Technical Advisory Group (NITAG) provides independent guidance to Ministries of Health (MoH) and policymakers, enabling them to make informed decisions on national immunization policies and practices. As of 2022, 50 of the 53 countries in the World Health Organization (WHO) European Region (the Region) had established a NITAG, with 58% of all NITAGs and 66% of those in middle-income countries (MICs) in the Region meeting all six WHO process indicators of NITAG functionality. However, many newly established NITAGs in MICs in the Region experience challenges in terms of their functioning, structure, and outputs. . . . The main challenge for all NITAGs is the lack of a well-staffed Secretariat to establish annual workplans and develop NITAG recommendations following a standardized process.


Upcoming Events

ACIP meeting planned for February 26–28 postponed, not yet rescheduled

The ACIP meeting planned for February 26–28 was postponed and is not yet rescheduled. IZ Express will provide updates as they become available.


Questions about our website? Register for Immunize.org Website Office Hours March 12 at 4:00 p.m. (ET) or March 13 at 12:00 p.m. (ET). Previously recorded sessions available online.  

To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, March 12 at 4:00 p.m. (ET) or Thursday, March 13 at 12:00 p.m. (ET). The same content will be covered in both sessions. 
 
We will open each 45-minute session with a short, live demonstration on navigating the following site content: images, webinars, videos, and social media. You can submit questions when you register or live on Zoom during the session.



Register today for Immunize.org Website Office Hours (content is the same for both):

The archive of previous Website Office Hours content is posted at Immunize.org’s Webinars & Videos page. 

Mark your calendar for future Immunize.org Website Office Hours. 


For more upcoming events, visit our Calendar of Events.

About IZ Express

IZ Express is supported in part by Grant No. NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .